Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avnika B Amin

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
JAMA|June 12, 2024
Test-Negative Study Designs for Evaluating Vaccine EffectivenessNatalie Dean, Avnika B Amin
JAMA Pediatrics|August 15, 2017
Communicating About Vaccines in a Fact-Resistant WorldSaad B Omer, Avnika B Amin, Rupali J Limaye
Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)|April 14, 2026
Tetanus Surveillance - United States, 2009-2023Michelle M Hughes, Avnika B Amin, Amy B Rubis
Vaccine|March 31, 2018
Cancer-salient messaging for Human Papillomavirus vaccine uptake: A randomized controlled trialRachael M Porter, Avnika B Amin, Robert A Bednarczyk, et al.
The Pediatric Infectious Disease Journal|December 6, 2021
Do Rotavirus Strains Affect Vaccine Effectiveness? A Systematic Review and Meta-analysisJordan E Cates, Avnika B Amin, Jacqueline E Tate, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2022
Monovalent Rotavirus Vaccine Efficacy Against Different Rotavirus Genotypes: A Pooled Analysis of Phase II and III Trial DataAvnika B Amin, Jacqueline E Tate, Lance A Waller, et al.
American Journal of Epidemiology|January 2, 2025
Accounting for local incidence when estimating rotavirus vaccine efficacy among countries: a pooled analysis of monovalent rotavirus vaccine trialsAvnika B Amin, Lance A Waller, Jacqueline E Tate, et al.
MMWR. Morbidity and Mortality Weekly Report|January 8, 2026
Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025Avnika B Amin, Jennifer P Collins, Xiaoyu Dong, et al.
Vaccine|September 2, 2020
Immunogenicity of influenza vaccines administered to pregnant women in randomized clinical trials in Mali and South AfricaAvnika B Amin, Marta C Nunes, Milagritos D Tapia, et al.
Nature Human Behaviour|April 27, 2019
Association of moral values with vaccine hesitancyAvnika B Amin, Robert A Bednarczyk, Cara E Ray, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
JAMA|June 12, 2024
Test-Negative Study Designs for Evaluating Vaccine EffectivenessNatalie Dean, Avnika B Amin
JAMA Pediatrics|August 15, 2017
Communicating About Vaccines in a Fact-Resistant WorldSaad B Omer, Avnika B Amin, Rupali J Limaye
Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)|April 14, 2026
Tetanus Surveillance - United States, 2009-2023Michelle M Hughes, Avnika B Amin, Amy B Rubis
Vaccine|March 31, 2018
Cancer-salient messaging for Human Papillomavirus vaccine uptake: A randomized controlled trialRachael M Porter, Avnika B Amin, Robert A Bednarczyk, et al.
The Pediatric Infectious Disease Journal|December 6, 2021
Do Rotavirus Strains Affect Vaccine Effectiveness? A Systematic Review and Meta-analysisJordan E Cates, Avnika B Amin, Jacqueline E Tate, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2022
Monovalent Rotavirus Vaccine Efficacy Against Different Rotavirus Genotypes: A Pooled Analysis of Phase II and III Trial DataAvnika B Amin, Jacqueline E Tate, Lance A Waller, et al.
American Journal of Epidemiology|January 2, 2025
Accounting for local incidence when estimating rotavirus vaccine efficacy among countries: a pooled analysis of monovalent rotavirus vaccine trialsAvnika B Amin, Lance A Waller, Jacqueline E Tate, et al.
MMWR. Morbidity and Mortality Weekly Report|January 8, 2026
Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025Avnika B Amin, Jennifer P Collins, Xiaoyu Dong, et al.
Vaccine|September 2, 2020
Immunogenicity of influenza vaccines administered to pregnant women in randomized clinical trials in Mali and South AfricaAvnika B Amin, Marta C Nunes, Milagritos D Tapia, et al.
Nature Human Behaviour|April 27, 2019
Association of moral values with vaccine hesitancyAvnika B Amin, Robert A Bednarczyk, Cara E Ray, et al.
Pageof 3